Januvia® (sitagliptin), Janumet®, Janumet XR (sitagliptin/metformin), Jentadueto®, Jentadueto XR (linagliptin/metformin), Tradjenta® (linagliptin), Glyxambi® (linagliptin/empagliflozin) – New warning
August 10, 2017 – The FDA approved updates to the Warnings and Precautions sections of the Januvia (sitagliptin), Janumet (sitagliptin/ metformin), Janumet XR (sitagliptin/metformin XR), Jentadueto (linagliptin/metformin), Jentadueto XR (linagliptin/metformin XR), Tradjenta (linagliptin), and Glyxambi (linagliptin/empagliflozin) drug labels regarding heart failure.
Top